DIETARY_SUPPLEMENT · Unmapped registry intervention
Bilberry
Find medicine records ·
Find other trials using this name
Clinical trial
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
NCT03620266
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DIETARY_SUPPLEMENT · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DIETARY_SUPPLEMENT · Unmapped registry intervention
Bioprocessed oat bran
Find medicine records ·
Find other trials using this name
DIETARY_SUPPLEMENT · Unmapped registry intervention
Combination bilberry/oats
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
BilberryDIETARY_SUPPLEMENT
PlaceboDIETARY_SUPPLEMENT
Bioprocessed oat branDIETARY_SUPPLEMENT
Combination bilberry/oatsDIETARY_SUPPLEMENT
Sponsors & collaborators
Ole Frobert, MD, PhDlead sponsor
Region Västmanlandcollaborator
Region Skanecollaborator
Chalmers University of Technologycollaborator
Värmland County Council, Swedencollaborator
Vastra Gotaland Regioncollaborator
Aarhus University Hospitalcollaborator
Odense University Hospitalcollaborator
Falu Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03620266 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.